Pell Bio-Med Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	611.48	427.37	167.68	172.4	115.78
Short-Term Investments	150	679.75	938.15	536	-
Trading Asset Securities	-	29.06	-	-	-
Cash & Short-Term Investments	761.48	1,136	1,106	708.4	115.78
Cash Growth	-46.50%	2.74%	56.10%	511.84%	-
Accounts Receivable	4.72	3.75	7.61	6.05	4.5
Other Receivables	2.96	0.56	0.33	0.36	6.12
Receivables	7.67	4.31	7.94	6.41	10.62
Inventory	5.77	6.18	3.76	4.58	4.24
Prepaid Expenses	12.54	9.22	8.86	5.84	1.1
Other Current Assets	200	1.84	0.65	0.16	0.08
Total Current Assets	987.47	1,158	1,127	725.39	131.82
Property, Plant & Equipment	550.13	386.45	260.92	298.97	249.74
Long-Term Investments	0.27	0.37	0.37	0.26	0.26
Other Intangible Assets	1.89	1.89	2.4	2.71	1.47
Other Long-Term Assets	120.88	198.39	27.44	17.07	10.61
Total Assets	1,661	1,745	1,418	1,044	393.89
Accounts Payable	4.47	4.49	6.99	5.72	8.61
Accrued Expenses	83.95	64.12	39.74	14.58	19.19
Short-Term Debt	200	200	-	5	-
Current Portion of Leases	27.77	27.55	25.09	25.07	10.76
Current Unearned Revenue	-	-	-	-	0.75
Other Current Liabilities	77.75	25.19	17.47	6.86	4.87
Total Current Liabilities	393.94	321.35	89.3	57.24	44.18
Long-Term Leases	123.33	137.27	147.47	172.56	124.84
Total Liabilities	517.27	458.62	236.77	229.79	169.02
Common Stock	583.92	578.43	539.43	443.65	333.76
Additional Paid-In Capital	1,817	1,804	1,449	774.25	77.38
Retained Earnings	-1,361	-1,207	-817.85	-419.09	-188.96
Treasury Stock	-0.8	-0.8	-0.8	-	-
Comprehensive Income & Other	5.25	5.52	-	2.13	2.69
Total Common Equity	1,044	1,180	1,170	800.94	224.86
Minority Interest	99.2	106.29	11.18	13.67	0.01
Shareholders' Equity	1,143	1,286	1,181	814.6	224.87
Total Liabilities & Equity	1,661	1,745	1,418	1,044	393.89
Total Debt	351.1	364.82	172.56	202.63	135.6
Net Cash (Debt)	410.39	771.36	933.27	505.77	-19.82
Net Cash Growth	-67.51%	-17.35%	84.52%	-	-
Net Cash Per Share	7.04	13.52	20.17	12.89	-0.60
Filing Date Shares Outstanding	58.31	57.8	53.9	44.36	33.28
Total Common Shares Outstanding	58.31	57.8	53.9	44.36	33.28
Working Capital	593.53	836.38	1,038	668.15	87.64
Book Value Per Share	17.91	20.41	21.71	18.05	6.76
Tangible Book Value	1,042	1,178	1,168	798.22	223.39
Tangible Book Value Per Share	17.87	20.38	21.67	17.99	6.71
Machinery	106.38	95.05	90.37	81.84	75.31
Construction In Progress	320.74	148.34	-	-	-
Leasehold Improvements	90.22	86.72	86.72	86.18	86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.